STXS — Stereotaxis, Inc.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1289340 ·
Last close
$1.70
Market Cap
$166.15M
52W High
$2.12
52W Low
$1.59
ADV30
533,340
Next earnings
2026-05-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 6,291,000 | 3,794,000 | -5,981,000 | -5,861,000 | 54,030,000 | 14,616,000 | 34,432,000 |
| Dec 2025 | 8,642,000 | 4,327,000 | -5,649,000 | -5,531,000 | 52,251,000 | 13,421,000 | 33,530,000 |
| Sep 2025 | 7,464,000 | 4,101,000 | -6,557,000 | -6,463,000 | 45,587,000 | 10,506,000 | 34,053,000 |
| Jun 2025 | 8,798,000 | 4,579,000 | -3,977,000 | -3,826,000 | 41,173,000 | 6,967,000 | 34,421,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-15,348,000
Investing CF
$-172,000
Financing CF
$19,447,000
CapEx
$-161,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.24
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-589,229,000
Inventory
$10,495,000
Receivables
$9,619,000
ST Investments
—
EBIT TTM
$-22,164,000
Pretax Income TTM
$-21,681,000
Interest Exp TTM
—
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$31,196,000
EBITDA
$-18,159,000
Free Cash Flow
$-8,817,875
Enterprise Value
$165,965,856
Total Cash
$14,616,000
Total Debt
$5,280,000
Shares Out
97,736,700
Trailing EPS
$-0.24
Book Value
$0.15
ROE
-156.1%
ROA
-24.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 32,377,000 | -22,112,000 | -21,643,000 | 52,251,000 | 33,530,000 | — | -13,685,000 |
| Dec 2024 | 26,918,000 | -24,739,000 | -24,045,000 | 46,724,000 | 35,292,000 | — | -8,497,000 |
| Dec 2023 | 26,771,000 | -21,839,000 | -20,713,000 | 41,909,000 | 19,989,000 | — | -9,139,000 |
| Dec 2022 | 28,147,000 | -18,776,000 | -18,292,000 | 53,413,000 | 21,484,000 | — | -8,415,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.13
Max Pain — expiry 2026-08-21
max pain strike: $2.50 · spot: $1.70 · call oi: 1,250 · put oi: 159
Expected Move to 2026-08-21:
±$0.79
(46.47%) —
implied range
$0.91 –
$2.49
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NYXH | Nyxoah SA | $171.12M | $1.71 | — |
| INGN | Inogen Inc | $177.07M | $6.54 | — |
| APYX | Apyx Medical Corp | $184.44M | $4.38 | — |
| LUCD | Lucid Diagnostics Inc. | $190.77M | $1.00 | — |
| CVRX | CVRx, Inc. | $144.09M | $5.43 | — |
News headlines (Yahoo Finance, 1h cache)
ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now?
2026-07-10 18:10 · Yahoo
Stereotaxis closes Robocath takeover
2026-07-09 17:00 · Yahoo
Stereotaxis Completes Acquisition of Robocath
2026-07-09 12:08 · Yahoo
Citizens Sees Compelling Razor/Razor Blade Ecosystem As A Driver Of Sustainable Growth For Stereotaxis (STXS)
2026-06-30 02:04 · Yahoo
ISRG's Capital Placement Surge: Demand Strength or Upgrade Cycle Peak?
2026-06-15 14:31 · Yahoo
ISRG's Ion Platform: A Major Growth Engine in Lung Cancer Care?
2026-05-25 15:16 · Yahoo
Analysts See 124.7% Upside In Stereotaxis (STXS); Find Out Why
2026-05-24 13:06 · Yahoo
Stereotaxis Inc (STXS) Q1 2026 Earnings Call Highlights: Navigating Regulatory Wins and Revenue ...
2026-05-13 05:02 · Yahoo
Stereotaxis Inc. (STXS) Reports Q1 Loss, Lags Revenue Estimates
2026-05-12 21:40 · Yahoo
Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates
2026-05-12 20:06 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.